SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-077843
Filing Date
2016-01-29
Accepted
2016-01-29 15:12:06
Documents
6
Period of Report
2016-01-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v430060_8k.htm 8-K 17983
2 EXHIBIT 10.1 v430060_ex10-1.htm EX-10.1 7291
3 EXHIBIT 99.1 v430060_ex99-1.htm EX-99.1 7684
4 EXHIBIT 99.2 v430060_ex99-2.htm EX-99.2 9676
5 GRAPHIC tex99-1logo.jpg GRAPHIC 5964
6 GRAPHIC tex99-2logo.jpg GRAPHIC 5964
  Complete submission text file 0001144204-16-077843.txt   60669
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 161373000
SIC: 2834 Pharmaceutical Preparations